Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The role of dupilumab in the treatment of eosinophilic esophagitis.
Journal: Immunotherapy
Published: July 29, 2024
Piloting a multidisciplinary group education session to support caregivers of children with food protein-induced enterocolitis syndrome (FPIES).
Journal: The journal of allergy and clinical immunology. In practice
Published: March 09, 2023
Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis.
Journal: Gastroenterology & hepatology
Published: May 04, 2022
Treatment for eosinophilic esophagitis.
Journal: Current opinion in gastroenterology
Published: October 03, 2020
Oral viscous mometasone is an effective treatment for eosinophilic esophagitis.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 14, 2019
Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders.
Journal: Clinical reviews in allergy & immunology
Published: September 13, 2018
Mechanical Skin Injury Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion.
Journal: Immunity
Published: August 17, 2018
Dibutyl-phthalate exposure from mesalamine medications and serum thyroid hormones in men.
Journal: International journal of hygiene and environmental health
Published: June 25, 2018
A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and serum reproductive hormones in men.
Journal: Environmental research
Published: June 14, 2017
High Prevalence of Eosinophilic Gastrointestinal Disease in Children With Intestinal Failure.
Journal: Journal of pediatric gastroenterology and nutrition
Published: August 23, 2016
A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and semen quality in men with inflammatory bowel disease.
Journal: Environment international
Published: May 30, 2016
Urinary phthalate metabolite concentrations among men with inflammatory bowel disease on mesalamine therapy.
Journal: Endocrine disruptors (Austin, Tex.)
Published: November 14, 2014
Last Updated: 09/26/2026